BusinessCURE Pharmaceutical Attracts Strategic Investment to Speed Its Cannabinoid Drug Delivery ProductionBy Nasdaq OMXMay 1, 2018, 12:57 PM UTC
BusinessKannalife Sciences CEO Dean Petkanas to Provide Presentation on Industry Advancement at 2018 Cannabinoids in Medicine SummitBy Nasdaq OMXApr 27, 2018, 2:00 PM UTC
BusinessAXIM Biotech Secures Additional Funding to Advance Cannabidnoid-Based Clinical Development Program for Multiple IndicationsBy Nasdaq OMXApr 23, 2018, 1:00 PM UTC
BusinessAXIM Biotech Files Patent Application on Product Formulation Comprised of Cannabinoids With Anti-Bacterial and Anti-Fungal ActivitiesBy Nasdaq OMXApr 18, 2018, 1:01 PM UTC
BusinessLiveWire Ergogenics Purchases Two Self-Contained Cloning Pods to Add to its Coachella Cultivation and Nursery OperationBy Nasdaq OMXApr 12, 2018, 1:01 PM UTC
BusinessCURE Pharmaceutical Secures Two Patents for the Extraction and Purification of Bioactive Cannabinoid MoleculesBy Nasdaq OMXApr 4, 2018, 12:57 PM UTC
BusinessAXIM Biotech Reaches Preliminary Agreement for Distribution of CanChew and MedChew Products Throughout South KoreaBy Nasdaq OMXApr 3, 2018, 1:02 PM UTC
